NCT05093322 2024-06-07A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid TumorsHutchmedPhase 1/2 Completed13 enrolled 17 charts
NCT03458728 2023-12-04Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric PatientsBayerPhase 1/2 Terminated31 enrolled 17 charts
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT01169584 2016-01-21Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsSillaJen, Inc.Phase 1 Completed6 enrolled